CNS Pharmaceuticals, Inc.

CNSP

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001683168-26-001491
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Restricted Stock Units

Action

Grant

Date

2026-03-02

Code

A

Net shares

+9,500.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

9,500.0

Filing's footnotes

1. Each restricted stock unit represents a contingent right to receive one share of Company common stock.

2. The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.

3. Issued in connection with the reporting person's employment with the Company.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.